A Study for the Neoadjuvant Treatment of Breast Cancer

NCT05420454 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1576

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Nab paclitaxel
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Nab paclitaxel

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University